Amina Zafar

Health Canada has approved the first drug designed to treat postpartum depression. The regulator says zuranolone, a pill sold under the brand name Zurzuvae, is authorized in Canada to relieve symptoms of moderate or severe depression after childbirth.

| CBC News | Posted: December 11, 2025 12:12 AM | Last Updated: Just now Influenza cases rising across Canada

Health officials are reminding Canadians to maintain healthy habits during the holiday season, as influenza leads to more school absences and hospitalizations.

In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer cheaper generic versions of medications like Ozempic and Wegovy to people with prescriptions. Pharmaceutical experts say this could take some time.

Weight lost on medications likely to be regained in under two years, review of studies suggests

Some emergency departments across Canada report that the rapid spread of influenza has contributed to overcrowding, as some children and adults face long-lasting fevers, with the latest federal report showing a slight declining picture of flu activity across the country.

Pay attention to the link between heart and brain health, new Canadian recommendations say.

Pay attention to the link between heart and brain health, new Canadian recommendations say.

As of Wednesday, the federal government will require provinces and territories to start to pay for primary care services, including those provided by nurse practitioners. The new policy aims to ensure Canadians aren't being billed for "medically necessary services."

Companies are selling peptides on the grey market, despite warnings from Health Canada.